Wednesday, February 10, 2010, 3:07am EST - Canadian Markets open in 6 hours and 23 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Inverness Medical Innovations Inc. (IMA)

 On Feb 9: 41.17 USD   0.00 (0.00%)  
MORE ON IMA
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
INVERNESS MED INNOVA (NYSE:IMA) Delayed quote dataEdit
Last Trade: 41.17 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 41.17
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 74.25
Day's Range: N/A - N/A
52wk Range: 20.99 - 44.87
Volume: 0
Avg Vol (3m): 507,946
Market Cap: 3.43B
P/E (ttm): N/A
EPS (ttm): -4.97
Div & Yield: N/A (N/A%)
Inverness Medical Innovations Inc. (IMA)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add IMA to Portfolio   Download Data

HEADLINES
• Inverness to buy Marsh & McLennan unit
at bizjournals.com (Thu, Feb 4)
• Alere's Dr. Michael Taitel Presents Compelling Evidence at IBI/NBCH Health & Productivity Forum that Wellness Programs Positively Impact Health & Prod
PRNewswire (Thu, Feb 4)
• Deals of the day -- mergers and acquisitions
at Reuters (Thu, Feb 4)
• UPDATE - Inverness to buy drug abuse testing firm for $110 mln
at Reuters (Wed, Feb 3)
• Inverness Medical Innovations to Acquire Kroll Laboratory Specialists, Inc.
PRNewswire (Wed, Feb 3)
• 3 Best Hedge Fund Healthcare Ideas
at Seeking Alpha (Wed, Feb 3)
• 4-Star Stocks on the Upswing
at Motley Fool (Tue, Feb 2)
• Curing Health Care at Philips
at The Wall Street Journal Online (Mon, Feb 1)
• Inverness closes on Standard Diagnostics
at bizjournals.com (Mon, Feb 1)
• Inverness Medical Innovations Announces Successful Tender Offer
PRNewswire (Mon, Feb 1)
• Inverness Medical Innovations to Present at the UBS 20th Annual Global Healthcare Services Conference on February 9, 2010
PRNewswire (Mon, Feb 1)
• Genomic Testing Systems Create Sustainable Competitive Advantage For Selected Medical Diagnostic Stocks According To Award Winning Equity Analyst
Wall Street Transcript (Mon, Jan 25)
More Headlines for IMA...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.7
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Inverness Medical Innovations, Inc. engages in the development, manufacture, and marketing of in vitro diagnostic products for the over-the-counter pregnancy and fertility/ovulation, and the professional diagnostic test markets worldwide.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices